In this article, we will discuss Durvalumab (Dosage-1). So, let’s get started.
Unresectable stage III NSCLC
- Patients with a body weight of 30 kg and more: 10 mg/kg every 2 weeks or 1,500 mg every 4 weeks
- Patients with a body weight of less than 30 kg: 10 mg/kg every 2 weeks